Andrew O. Larsen, Ph.D.

Associate
New York
767 Third Avenue, Suite 23C
New York, NY 10017
D: 212.223.6658
Contact My Assistant
Julie Harting
D: 212.223.6528

Education

Fordham University School of Law
J.D., 2010

Boston College
NIH Postdoctoral Fellow, 2002-2004

University of North Carolina
Ph.D. Organic Chemistry, 2002

College of William and Mary
B.S. Chemistry, 1996

Bar and Court Admissions

U.S. Patent and Trademark Office
New York Bar

Professional Affiliations

New York State Bar Association

Publications & Speaking

Bidentate NHC-Based Chiral Ligands for Efficient Cu-Catalyzed Enantioselective Allylic Alkylations: Structure and Activity of an Air-Stable Chiral Cu Complex, Journal of the American Chemical Society, 126: 11130-11131, Andrew Larsen, Ph.D., J.E. Campbell, A.H. Hoveyda, W. Leu, C.N. Oberhuber (2004)

Ethylene-Linked Bisphenol Ligands: Efficient Synthesis, Titanium Coordination Chemistry and Lewis Acid Catalysis, Journal of Organometallic Chemistry, 15: 121-124, Andrew Larsen, Ph.D., J.W. Anthis, M.R.Gangé, P.S. White (2003)

Disparate Roles of Chiral Ligands and Molecularly Imprinted Cavities in Asymmetric Catalysis and Chiral Poisoning, Organometallics, 21: 7-9, Andrew Larsen, Ph.D., M.R. Gangé, J.H. Koh, P.S. White (2002)

Asymmetric Pt(II)-Catalyzed Ene Reactions: Counterion Dependent Additive and Diphosphine Electronic Effects, Organic Letters, 3: 1233-1236, Andrew Larsen, Ph.D., M.R. Gangé, J.H. Koh (2001)

Asymmetric Synthesis of Rigid C2-Symmetric Bis(ferrocenyl) Diol and Diamine Ligands, Organometallics 1999, 18, 5157-5162; Andrew Larsen, Ph.D., R. A. Taylor, P. S. White and M. R. Gagné

Acid-Base Adducts of Catalytically Active Titanium(IV) Lewis Acids, Inorg. Chem. 1999, 38, 4824-4828; Andrew Larsen, Ph.D., P. S. White and M. R. Gagné

In helping his clients determine whether and when to get into the market, Andrew’s goal is to prepare a comprehensive pre-litigation strategy that allows for confident, well-informed and well-timed decisions.

Andrew is an associate in Merchant & Gould’s New York office. He focuses his practice on IP counseling matters and Hatch-Waxman litigation. He assists pharmaceutical, biotechnology, and chemical companies with developing and strengthening their IP estates and their litigation strategy, including pre-litigation activities and Paragraph IV Certifications, filings, fact and expert discovery, claim construction advice and briefing, and deposition and motion practice.  Andrew also dedicates significant time to freedom-to-operate, validity and infringement investigations, and post-grant proceedings at the USPTO (including interference and inter partes review), as well as due diligence, licensing, patent procurement and life cycle management advice for a wide range of industries.

Throughout his academic and legal career, Andrew has garnered an extensive technical understanding within multiple disciplines, including organic, medicinal, organometallic and polymer chemistry, which has allowed him to provide a thorough, and often unique, perspective on how to navigate the existing IP landscape. This diverse experience set is invaluable to his legal practice relating to, for example, pharmaceutics and pharmaceutical dosage form design, diversity oriented synthesis and the preparation and screening of large chemical libraries, x-ray crystallography and solid-state drug forms, catalyst design, plastics and adhesives, CNTs and other nanotechnology, semi-conductors, LCD and LED displays, solar energy and medical devices.  

Prior to joining Merchant & Gould, Andrew was a patent agent at an intellectual property law firm in New York. He was also a recipient of the NIH Ruth Kirschstein National Research Service Award (NRSA) for postdoctoral studies directed to novel methods in catalytic and enantioselective organic synthesis and their application to the total synthesis of complex natural product targets. During his graduate work at The University of North Carolina, Andrew researched approaches to asymmetric synthesis using polymer supported early and late transition metal-based catalyst systems and the concept of molecular imprinting.

Andrew enjoys technical scuba diving, photography, philosophy, cycling, music and the great outdoors.